Skip to main content
Amgen10-K: Competitor named

Amgen names key partners and M&A counterparties including Kyowa Kirin, Takeda, and Bristol Myers Squibb

What happened

Amgen's filing details its ecosystem of partners, particularly in the Asia Pacific region, which includes Astellas, Takeda, and Kyowa Kirin. It also notes its acquisition of Otezla from Bristol Myers Squibb, highlighting its interactions with major industry players that are both collaborators and competitors.

Source

SEC EDGARFeb 13, 2026

Annual report (Form 10-K)

Amgen 10-K for FY2025

Filing excerpt

In the Asia Pacific region, we also sell our products in partnership with other companies, including Astellas Pharma Inc., BeOne, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd. and Kyowa Kirin.

sec.gov/Archives/edgar/data/318154/000031815426000010/amgn-20251231.htmRead the full source

Other signals in this filing (4)

Extracted by Autobound

From the Signal API record
Signal
10-K: Competitor named

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 13, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Numbers

Percent
77% (Combined percentage of worldwide gross revenues from three main wholesalers (McKesson, Cencora, Cardinal Health) in 2025)

Details

CIK
318154
Accession number
0000318154-26-000010
Timeframe
Current year
Filing year
2026
Why it matters
Competitive intelligence
Signal category
Market

Topics and mentions

Vendors

  • McKesson Corporation
  • Cencora
  • Inc.
  • Cardinal Health

Competitors

  • Astellas Pharma Inc.
  • BeOne
  • Mitsubishi Tanabe Pharma Corporation
  • Takeda Pharmaceutical Co.
  • Ltd.
  • Kyowa Kirin
  • Bristol Myers Squibb Company
  • Celgene Corporation

Regions named

  • Asia Pacific region

Vendors named

  • McKesson Corporation
  • Cencora, Inc.
  • Cardinal Health, Inc.

Competitors named

  • Astellas Pharma Inc.
  • BeOne
  • Mitsubishi Tanabe Pharma Corporation
  • Takeda Pharmaceutical Co., Ltd.
  • Kyowa Kirin
  • Bristol Myers Squibb Company
  • Celgene Corporation

Extraction

Confidence
High
Relevance
70%
Sentiment
Neutral
Detected
Feb 17, 2026
signal_type
sec-10k
signal_subtype
competitorNamed

Use this data

Get every 10-K signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b1f57c82-de41-470e-bafc-e1a5b5acaa7f returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "b1f57c82-de41-470e-bafc-e1a5b5acaa7f",
  "signal_type": "sec-10k",
  "signal_subtype": "competitorNamed",
  "detected_at": "2026-02-17T06:28:58.463+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "Amgen's filing details its ecosystem of partners, particularly in the Asia Pacific region, which includes Astellas, Takeda, and Kyowa Kirin. It also notes its acquisition of Otezla from Bristol Myers Squibb, highlighting its interactions with major industry players that are both collaborators and competitors.",
    "metrics": {
      "pct": 0.77,
      "timeframe": "current_year",
      "pct_context": "Combined percentage of worldwide gross revenues from three main wholesalers (McKesson, Cencora, Cardinal Health) in 2025"
    },
    "summary": "Amgen names key partners and M&A counterparties including Kyowa Kirin, Takeda, and Bristol Myers Squibb",
    "excerpts": "In the Asia Pacific region, we also sell our products in partnership with other companies, including Astellas Pharma Inc., BeOne, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd. and Kyowa Kirin.",
    "relevance": 0.7,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/amgn-20251231.htm",
    "filing_date": "2026-02-13",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Competitive intelligence",
    "signal_category": "market",
    "regions_mentioned": [
      "Asia Pacific region"
    ],
    "vendors_mentioned": [
      "McKesson Corporation",
      "Cencora, Inc.",
      "Cardinal Health, Inc."
    ],
    "competitors_mentioned": [
      "Astellas Pharma Inc.",
      "BeOne",
      "Mitsubishi Tanabe Pharma Corporation",
      "Takeda Pharmaceutical Co., Ltd.",
      "Kyowa Kirin",
      "Bristol Myers Squibb Company",
      "Celgene Corporation"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.